Page last updated: 2024-12-07

n-acetyltryptophanamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

N-acetyltryptophanamide is a synthetic derivative of tryptophan, an amino acid. It is studied for its potential therapeutic effects, particularly in relation to sleep, mood, and anxiety. Research has shown that it may have a sedative effect and could be useful in treating insomnia. The compound is also being investigated for its potential to modulate neurotransmitter levels and its potential as an anti-inflammatory agent. The mechanism of action for its effects is not fully understood, but it is thought to interact with serotonin receptors in the brain. Synthesis typically involves acetylation of the amino group of tryptophan followed by amide formation with an appropriate amine.'

Cross-References

ID SourceID
PubMed CID94230
CHEMBL ID390937
CHEBI ID108588
SCHEMBL ID455277
MeSH IDM0067346

Synonyms (46)

Synonym
BRD-K10171338-001-02-1
KBIO1_000359
DIVK1C_000359
acetyltryptophanamide
BSPBIO_003010
IDI1_000359
SPECTRUM5_001632
n-acetyl-l-tryptophanamide
KBIOGR_000782
KBIO3_002230
NINDS_000359
SPBIO_001531
SPECTRUM3_001395
SPECTRUM4_000431
SPECTRUM2_001346
SPECTRUM1500699
N-ACETYL-TRYPTOPHANAMIDE
CHEBI:108588
ac-trp-nh2
CHEMBL390937
HMS501B21
2382-79-8
HMS1921E10
(2s)-2-acetamido-3-(1h-indol-3-yl)propanamide
n-acetyltryptophanamide
einecs 219-189-8
CCG-39284
(s)-2-acetamido-3-(1h-indol-3-yl)propanamide
AKOS015898432
acetyl-l-tryptophan amide
SCHEMBL455277
n-alpha-acetyl-l-tryptophane amide
mfcd00005646
HNGIZKAMDMBRKJ-LBPRGKRZSA-N
2-(acetylamino)-3-(1h-indol-3-yl)propanamide #
1h-indole-3-propanamide, .alpha.-(acetylamino)-, (s)-
nata
Q27187511
1h-indole-3-propanamide,a-(acetylamino)-,(as)-
ac-l-trp-nh2
J-015231
DS-16118
D70379
DTXSID60946617
2-[(1-hydroxyethylidene)amino]-3-(1h-indol-3-yl)propanimidic acid
CS-0154019
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (4)

ClassDescription
primary carboxamideA carboxamide resulting from the formal condensation of a carboxylic acid with ammonia; formula RC(=O)NH2.
secondary carboxamideA carboxamide resulting from the formal condensation of a carboxylic acid with a primary amine; formula RC(=O)NHR(1).
acetamidesCompounds with the general formula RNHC(=O)CH3.
L-tryptophan derivativeA proteinogenic amino acid derivative resulting from reaction of L-tryptophan at the amino group or the carboxy group, or from the replacement of any hydrogen of L-tryptophan by a heteroatom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID288184Permeability coefficient through artificial membrane in presence of unstirred water layer by PAMPA2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
QSAR study on permeability of hydrophobic compounds with artificial membranes.
AID288192Partition coefficient, log P of the compound2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
QSAR study on permeability of hydrophobic compounds with artificial membranes.
AID1601164Binding affinity to human C5a assessed as Potassium iodide-induced quenching by measuring Stern-Volmer quenching constant at 1 uM by fluorescence analysis (Rvb = 4.1/M)2019Bioorganic & medicinal chemistry, 10-01, Volume: 27, Issue:19
A rational search for discovering potential neutraligands of human complement fragment 5a (
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (76)

TimeframeStudies, This Drug (%)All Drugs %
pre-199017 (22.37)18.7374
1990's18 (23.68)18.2507
2000's20 (26.32)29.6817
2010's19 (25.00)24.3611
2020's2 (2.63)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.15 (24.57)
Research Supply Index4.37 (2.92)
Research Growth Index4.52 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.28%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other77 (98.72%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]